14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
ESCA vs CMT: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Escalade Inc (ESCA) is the stronger overall head-to-head candidate over Core Molding Technologies, Inc. (CMT) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). ESCA carries a Unified Composite Score of 37.1/100 (SELL) at $20.94 (17.8x Forward P/E, 8.3% operating margin), whereas CMT carries 51.8/100 (HOLD) at $21.52 (11.6x Forward P/E, 3.8% operating margin).
Composite vs. Pillar Nuance: While CMT currently prints a higher short-term Unified Composite Score (51.8/100 HOLD vs. ESCA 37.1/100 SELL), ESCA captures the overall institutional head-to-head verdict (7–3 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (8.3% vs. 3.8% operating margin) and revenue trajectory (-3.2% vs. +54.4% YoY).
Technical & Structure Timing Caution: ESCA trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 54.5); meanwhile CMT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 43.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ESCA vs CMT. Trailing 12-month operating profitability (ESCA 8.3% vs CMT 3.8%) and valuation multiples (ESCA 17.8x vs CMT 11.6x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Specialty Chemicals value chain with $187.0M market capitalization and 3.8% operating margin.
OpEx & R&D Reinvestment13.5% of Rev ($39M)
90D Engineering Disclosures0 Published
Investor FAQ ESCA vs CMT Key Questions & Quantitative Answers
As of Nov 20, 2026, Escalade Inc (ESCA) is the stronger overall head-to-head candidate over Core Molding Technologies, Inc. (CMT) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). ESCA carries a Unified Composite Score of 37.1/100 (SELL) at $20.94 (17.8x Forward P/E, 8.3% operating margin), whereas CMT carries 51.8/100 (HOLD) at $21.52 (11.6x Forward P/E, 3.8% operating margin). Composite vs. Pillar Nuance: While CMT currently prints a higher short-term Unified Composite Score (51.8/100 HOLD vs. ESCA 37.1/100 SELL), ESCA captures the overall institutional head-to-head verdict (7–3 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (8.3% vs. 3.8% operating margin) and revenue trajectory (-3.2% vs. +54.4% YoY). Technical & Structure Timing Caution: ESCA trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 54.5); meanwhile CMT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 43.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CMT leads the Growth & Scale pillar: ESCA posts -3.2% YoY revenue growth and +20.0% YoY earnings growth on $242M TTM revenue (28.5% gross margin, 8.3% operating margin), compared with CMT at +54.4% YoY revenue growth and -22.5% YoY earnings growth on $286M TTM revenue (17.3% gross margin, 3.8% operating margin). On trailing 12-month operating scale, ESCA generates $242M in USD-normalized revenue versus $286M for CMT. In operating R&D and SG&A reinvestment, ESCA deploys 20.2% of Rev ($49M) (0 90-day corporate R&D disclosures) versus 13.5% of Rev ($39M) (0 disclosures) for CMT.
CMT screens cheaper on headline valuation multiples. ESCA trades at 17.8x Forward P/E, 12.1x Trailing P/E, 1.05x PEG, and 1.2x EV/Revenue (10.4% EBITDA margin), whereas CMT trades at 11.6x Forward P/E, 26.7x Trailing P/E, 0.36x PEG, and 0.7x EV/Revenue (-3.9% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ESCA (13.5% ROE) versus CMT (4.4% ROE) capital efficiency.
In options market volatility and institutional positioning, ESCA carries 38.7% implied volatility (7th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.63β · 48% Vol realized risk). By comparison, CMT carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.48β · 50% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.